KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $642,769 | -8.2% | 70,479 | +6.5% | 0.00% | – |
Q2 2023 | $700,016 | -29.9% | 66,164 | -19.0% | 0.00% | – |
Q1 2023 | $998,926 | +104.5% | 81,678 | +107.5% | 0.00% | – |
Q4 2022 | $488,435 | -46.5% | 39,358 | -41.1% | 0.00% | – |
Q3 2022 | $913,000 | -24.8% | 66,823 | +0.8% | 0.00% | – |
Q2 2022 | $1,214,000 | +13.5% | 66,270 | -0.4% | 0.00% | – |
Q1 2022 | $1,070,000 | -98.6% | 66,548 | -98.8% | 0.00% | -100.0% |
Q4 2021 | $78,151,000 | -33.0% | 5,582,200 | -10.3% | 0.01% | -33.3% |
Q3 2021 | $116,589,000 | -28.3% | 6,224,773 | -20.2% | 0.01% | -30.8% |
Q2 2021 | $162,713,000 | -37.3% | 7,803,975 | -15.0% | 0.01% | -40.9% |
Q1 2021 | $259,503,000 | -12.8% | 9,179,469 | +0.7% | 0.02% | -15.4% |
Q4 2020 | $297,730,000 | +34.2% | 9,116,040 | +25.9% | 0.03% | +18.2% |
Q3 2020 | $221,809,000 | +68.3% | 7,239,188 | -10.5% | 0.02% | +57.1% |
Q2 2020 | $131,780,000 | +94.4% | 8,084,683 | +18.6% | 0.01% | +55.6% |
Q1 2020 | $67,801,000 | -27.5% | 6,814,206 | +0.3% | 0.01% | -10.0% |
Q4 2019 | $93,462,000 | -8.5% | 6,797,202 | +1.0% | 0.01% | -16.7% |
Q3 2019 | $102,139,000 | +6.5% | 6,732,989 | +38.2% | 0.01% | +9.1% |
Q2 2019 | $95,908,000 | +213.2% | 4,870,878 | +163.9% | 0.01% | +175.0% |
Q1 2019 | $30,625,000 | -4.6% | 1,846,010 | -19.2% | 0.00% | 0.0% |
Q4 2018 | $32,089,000 | -19.8% | 2,285,510 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $39,996,000 | -34.7% | 2,285,510 | -32.1% | 0.00% | -42.9% |
Q2 2018 | $61,269,000 | -26.3% | 3,366,419 | -24.1% | 0.01% | -30.0% |
Q1 2018 | $83,128,000 | +161.1% | 4,433,515 | +113.0% | 0.01% | +150.0% |
Q4 2017 | $31,842,000 | -17.7% | 2,081,171 | -19.6% | 0.00% | -20.0% |
Q3 2017 | $38,674,000 | +47.7% | 2,586,919 | -8.1% | 0.01% | +66.7% |
Q2 2017 | $26,188,000 | +5.7% | 2,815,919 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $24,780,000 | +49.2% | 2,815,919 | 0.0% | 0.00% | +50.0% |
Q4 2016 | $16,614,000 | -5.6% | 2,815,919 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $17,599,000 | +130.6% | 2,815,919 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $7,631,000 | -39.2% | 2,815,919 | -9.1% | 0.00% | -50.0% |
Q1 2016 | $12,544,000 | -52.0% | 3,097,354 | -0.5% | 0.00% | -50.0% |
Q4 2015 | $26,155,000 | – | 3,113,719 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |